COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco, CA on Tuesday, March 4, 2008 at 12:50 pm PST (3:50 pm EST).
